Matthew Prihoda
Family Medicine · Washington, IANPI 1184663684
Payments from drug & device makers
Across 108 payments — averaging $12.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$512
- Pfizer$179
- AstraZeneca$140
- Amgen$107
- Ironshore Pharmaceuticals Inc.$54
- Teva Pharmaceuticals USA, Inc.$51
- plus $325 from 14 others
What the payments were for
- Food & beverage$1,34899%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 34 | $512 |
| Pfizer | 27 | $179 |
| AstraZeneca | 7 | $140 |
| Amgen | 7 | $107 |
| Ironshore Pharmaceuticals Inc. | 4 | $54 |
| Teva Pharmaceuticals USA, Inc. | 4 | $51 |
| GSK | 4 | $46 |
| Novo Nordisk | 3 | $42 |
| Boehringer Ingelheim | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $29 |
| Novartis | 2 | $27 |
| AbbVie(2 entities) | 2 | $25 |
| Johnson & Johnson | 2 | $24 |
| Tris Pharma Inc | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$1,368 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 249 | $79,183 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,568 |
| JardianceEmpagliflozin | 17 | $14,065 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $9,701 |
| FarxigaDapagliflozin Propanediol | 12 | $9,004 |
| Aripiprazole | 35 | $8,713 |
| ExelonRivastigmine | 25 | $8,543 |
| GemtesaVibegron | 17 | $8,119 |
| Clomipramine Hcl | 15 | $6,688 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $6,584 |
| XareltoRivaroxaban | 14 | $6,219 |
| MyrbetriqMirabegron | 11 | $5,492 |
| Atorvastatin Calcium | 438 | $4,099 |
| NamzaricMemantine Hcl/Donepezil Hcl | 12 | $3,089 |
| Levothyroxine Sodium | 352 | $2,794 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $179 | $79,183249 claims |
| GSKTrelegy Ellipta | $46 | $20,56830 claims |
| Boehringer IngelheimJardiance | $38 | $14,06517 claims |
| AstraZenecaFarxiga | $140 | $9,00412 claims |
| NovartisExelon | $27 | $8,54325 claims |
| Johnson & JohnsonXarelto | $24 | $6,21914 claims |
| Astellas Pharma US IncMyrbetriq | $14 | $5,49211 claims |
| AbbVieNamzaric | $25 | $3,08912 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $2,794352 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Washington
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.